Influence of probucol on cholesterol and lipoprotein metabolism in man.

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Efficient Trace-labelling of Proteins with Iodine

1958 • 2,571 citations

The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations

1972 • 1,831 citations

Quantitative isolation and gas–liquid chromatographic analysis of total fecal bile acids

1965 • 891 citations

The Theory of Tracer Experiments with ¹³¹I-Labelled Plasma Proteins

1957 • 834 citations

Quantitative isolation and gas–liquid chromatographic analysis of total dietary and fecal neutral steroids

1965 • 760 citations

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

1983 • 562 citations

Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase

1978 • 556 citations

The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins.

1972 • 434 citations

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.

1981 • 424 citations

Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans

1972 • 361 citations

Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism

1980 • 357 citations

Dietary β-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies

1968 • 265 citations

Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia

1981 • 262 citations

Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.

1975 • 256 citations

A Physiological Method for Estimation of Hepatic Secretion of Biliary Lipids in Man

1972 • 243 citations

THE LDL RECEPTOR LOCUS AND THE GENETICS OF FAMILIAL HYPERCHOLESTEROLEMIA

1979 • 233 citations

Receptor-mediated Catabolism of Low Density Lipoprotein in Man. QUANTITATION USING GLUCOSYLATED LOW DENSITY LIPOPROTEIN

1983 • 202 citations

Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia

1983 • 201 citations

Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen

1981 • 197 citations

Usefulness of chromic oxide as an internal standard for balance studies in formula-fed patients and for assessment of colonic function

1968 • 195 citations

Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man.

1978 • 155 citations

Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis

1981 • 121 citations

Familial hypercholesterolemia

1975 • 113 citations

A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase.

1979 • 110 citations

Automation in Analytical Chemistry

1958 • 104 citations

Hypocholesterolesmic Effect of 4,4′-(Isopropylidenedithio)-Bis(2,6-di-t-Butylphenol) (Probucol)

1970 • 103 citations

Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.

1982 • 92 citations

Diet and drugs in atherosclerosis.

1980 • 88 citations

Diet and Probucol in Lowering Cholesterol Concentrations

1977 • 83 citations

Treatment of homozygous familial hypercholesterolaemia with probucol.

1982 • 83 citations

Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.

1977 • 78 citations

The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.

1983 • 78 citations

Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia

1980 • 78 citations

COLESTIPOL PLUS NICOTINIC ACID IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA

1981 • 72 citations

Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia

1972 • 70 citations

Probucol

1978 • 68 citations

Probucol in hypercholesterolemia *1A double blind study

1980 • 37 citations

DISTRIBUTION AND DEGRADATION OF HUMAN SERUM ALBUMIN LABELED WITH I¹³¹ BY DIFFERENT TECHNIQUES

1957 • 36 citations

Probucol: A new cholesterol‐lowering drug effective in patients with type II hyperlipoproteinemia

1976 • 34 citations

Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat

1981 • 33 citations

Effect of probucol on cholesterol metabolism in the rat

1980 • 31 citations

Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia

1980 • 31 citations

The effect of [4,4′-(isopropylidenedithio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjects

1969 • 30 citations

Effect of probucol on the activity of postheparin plasma lipoprotein lipase and hepatic lipase

1981 • 27 citations

Cholesterol absorption, elimination and synthesis in coeliac disease

1982 • 25 citations

Treatment of severe and mild hypercholesterolaemia with probucol and neomycin..

1975 • 20 citations

Safety and Efficacy of Probucol During One Year of Administration

1974 • 17 citations

Effect of probucol in hyperlipidemic patients during two years of administration

1978 • 15 citations

Drug management of hypercholesterolemia

1979 • 15 citations

Biphenabid (Probucol): a new hypocholesterolemic agent.

1971 • 12 citations

Endocrine and metabolic indices during administration of a lipophilic bis‐phenol, probucol

1971 • 9 citations

Effect of probucol on bile composition in man.

1982 • 5 citations